Anti-interleukin 2-receptor antibodies: A comparative study with polyclonal antibodies in kidney transplantation: Preliminary results

被引：9

作者：

Martins, L ^{[1
]}

Henriques, AC

Dias, L

Sarmento, AM

Pereira, MC

Guimaraes, S

机构：

[1] Hosp Santo Antonio, Dept Nephrol, P-4050 Porto, Portugal

[2] Hosp Santo Antonio, Dept Transplant, P-4050 Porto, Portugal

来源：

TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 08期

关键词：

D O I：

10.1016/S0041-1345(00)01810-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2623 / 2625

页数：3

共 10 条

[1] Placebo-controlled study of a humanized anti-TAC monoclonal antibody in dual therapy for prevention of acute rejection after renal transplantation [J].

Charpentier, B ;

Thervet, E .

TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) :1331-1332

[2] Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression [J].

Hong, JC ;

Kahan, BD .

TRANSPLANTATION, 1999, 68 (05) :701-704

[3] Intraoperative T-cell depletion prior to completion of anastomoses by high-dose single ATG bolus as a new approach to improve long-term results after kidney transplantation [J].

Kaden, J ;

May, G ;

Strobelt, V ;

Groth, J ;

Muller, P .

TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :344-347

[4] Therapeutic strategies for optimal use of novel immunosuppressants [J].

Keown, PA .

TRANSPLANTATION PROCEEDINGS, 1999, 31 (04) :1790-1792

[5] Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients [J].

Nashan, B ;

Moore, R ;

Amlot, P ;

Schmidt, AG ;

Abeywickrama, K ;

Soulillou, JP .

LANCET, 1997, 350 (9086) :1193-1198

[6] INFECTIOUS-DISEASE COMPLICATIONS OF RENAL-TRANSPLANTATION [J].

RUBIN, RH ;

SNYDMAN, D ;

HARRINGTON, JT ;

MADIAS, NE ;

KING, A ;

MYER, K ;

SINGH, A .

KIDNEY INTERNATIONAL, 1993, 44 (01) :221-236

[7] INCREASED INCIDENCE OF LYMPHOPROLIFERATIVE DISORDER AFTER IMMUNOSUPPRESSION WITH THE MONOCLONAL-ANTIBODY OKT3 IN CARDIAC-TRANSPLANT RECIPIENTS [J].

SWINNEN, LJ ;

COSTANZONORDIN, MR ;

FISHER, SG ;

OSULLIVAN, EJ ;

JOHNSON, MR ;

HEROUX, AL ;

DIZIKES, GJ ;

PIFARRE, R ;

FISHER, RI .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (25) :1723-1728

[8] Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation [J].

Vincenti, F ;

Kirkman, R ;

Light, S ;

Bumgardner, G ;

Pescovitz, M ;

Halloran, P ;

Neylan, J ;

Wilkinson, A ;

Ekberg, H ;

Gaston, R ;

Backman, L ;

Burdick, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (03) :161-165

[9] Can antibody prophylaxis allow sparing of other immunosuppressives? [J].

Vincenti, F ;

Grinyo, J ;

Ramos, E ;

Nashan, B ;

Stuart, F ;

Kuypers, D ;

Brattstrom, C ;

Cho, S ;

Ekberg, H ;

Johnson, R .

TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :1246-1248

[10] Daclizumab: Novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation [J].

Vincenti, F .

TRANSPLANTATION PROCEEDINGS, 1999, 31 (06) :2206-2207

← 1 →